CAP BUSINESS CENTER, HERSTAL, C9
Reports Second Quarter 2026 Financial Results
Enters Into Securities Purchase Agreements for Registered Direct Offering
Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
Material disclosure
Reports Q1-2026 Results
2026 Warrants Terms and Conditions
Announces Fourth Quarter and Full-Year 2025 Financial Results
Acquires Exosome Diagnostics
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
No filings found
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Correspondence
Submission Upload